159
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Visual functions, ocular characteristics and visual quality of life in patients with homocystinuria

, ORCID Icon, ORCID Icon, & ORCID Icon
Received 03 Oct 2023, Accepted 02 Apr 2024, Published online: 17 Apr 2024

References

  • Janosík M, Sokolová J, Janosíková B, Krijt J, Klatovská V, Kozich V. Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C>T (p.R369C) in the cystathionine beta-synthase gene. J Pediatr. 2009;154(3):431–7. doi:10.1016/j.jpeds.2008.09.015.
  • Morris AA, Kožich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, Crushell E, Henderson MJ, Hochuli M, Huemer M, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017;40(1):49–74. doi:10.1007/s10545-016-9979-0.
  • Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, Burlina A, Cerone R, Couce ML, Garcia‐Cazorla A, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017;40(1):21–48. doi:10.1007/s10545-016-9991-4.
  • Gerrard A, Dawson C. Homocystinuria diagnosis and management: it is not all classical. J Clin Pathol. 2022;75(11):744–50. doi:10.1136/jcp-2021-208029.
  • Weber Hoss GR, Sperb-Ludwig F, Schwartz IVD, Blom HJ. Classical homocystinuria: a common inborn error of metabolism? An epidemiological study based on genetic databases. Mol Genet Genomic Med. 2020;8(6):e1214. doi:10.1002/mgg3.1214.
  • Gan-Schreier H, Kebbewar M, Fang-Hoffmann J, Wilrich J, Abdoh G, Ben-Omran T, Shahbek N, Bener A, Al Rifai H, Al Khal AL, et al. Newborn population screening for classic homocystinuria by determination of total homocysteine from Guthrie cards. J Pediatr. 2010;156(3):427–32. doi:10.1016/j.jpeds.2009.09.054.
  • Sörensen L, von Döbeln U, Åhlman H, Ohlsson A, Engvall M, Naess K, Backman-Johansson C, Nordqvist Y, Wedell A, Zetterström RH, et al. Expanded screening of one million Swedish babies with R4S and CLIR for post-analytical evaluation of data. Int J Neonatal Screen. 2020;6(2):42. doi:10.3390/ijns6020042.
  • Saito M, Marumo K. The effects of homocysteine on the skeleton. Curr Osteoporos Rep. 2018;16(5):554–60. doi:10.1007/s11914-018-0469-1.
  • Rahman M, Sharma M, Aggarwal P, Singla S, Jain N. Homocystinuria and ocular complications - a review. Indian J Ophthalmol. 2022;70(7):2272–8. doi:10.4103/ijo.IJO_309_22.
  • Magner M, Krupková L, Honzík T, Zeman J, Hyánek J, Kožich V. Vascular presentation of cystathionine beta-synthase deficiency in adulthood. J Inher Metab Dis. 2011;34(1):33–7. doi:10.1007/s10545-010-9146-y.
  • Ochoa-Ferraro A, Wanninayake S, Dawson C, Gerrard A, Preece MA, Geberhiwot T. A case series of cerebral venous thrombosis as the first manifestation of homocystinuria. Eur Stroke J. 2021;6(4):420–7. doi:10.1177/23969873211059479.
  • Almuqbil MA, Waisbren SE, Levy HL, Picker JD. Revising the psychiatric phenotype of homocystinuria. Genet Med. 2019;21(8):1827–31. doi:10.1038/s41436-018-0419-4.
  • Burke JP, O’Keefe M, Bowell R, Naughten ER. Ocular complications in homocystinuria–early and late treated. Br J Ophthalmol. 1989;73(6):427–31. doi:10.1136/bjo.73.6.427.
  • Wenzler EM, Rademakers AJ, Boers GH, Cruysberg JR, Webers CA, Deutman AF. Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol. 1993;115(2):162–7. doi:10.1016/S0002-9394(14)73919-4.
  • Harrison DA, Mullaney PB, Mesfer SA, Awad AH, Dhindsa H. Management of ophthalmic complications of homocystinuria. Ophthalmol. 1998;105(10):1886–90. doi:10.1016/S0161-6420(98)91035-1.
  • Strofaldi A, Khan AR, McManus JJ. Surface exposed free cysteine suppresses crystallization of human γD-Crystallin. J Mol Biol. 2021;433(22):167252. doi:10.1016/j.jmb.2021.167252.
  • Midena E, Marchione G, Di Giorgio S, Rotondi G, Longhin E, Frizziero L, Pilotto E, Parrozzani R, Midena G. Ultra-wide-field fundus photography compared to ophthalmoscopy in diagnosing and classifying major retinal diseases. Sci Rep. 2022;12(1):19287. doi:10.1038/s41598-022-23170-4.
  • Auger G, Winder S. Spectral domain OCT: an aid to diagnosis and surgical planning of retinal detachments. J Ophthalmol. 2011;2011:725362. doi:10.1155/2011/725362.
  • Coscas F, Glacet-Bernard A, Miere A, Caillaux V, Uzzan J, Lupidi M, Coscas G, Souied EH. Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol. 2016;161:160–71.e1–2. doi:10.1016/j.ajo.2015.10.008.
  • Prasad PS, Oliver SC, Coffee RE, Hubschman JP, Schwartz SD. Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion. Ophthalmology. 2010;117(4):780–4. doi:10.1016/j.ophtha.2009.09.019.
  • Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, Potsaid B, Liu JJ, Lu CD, Kraus MF, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2014;121(7):1435–44. doi:10.1016/j.ophtha.2014.01.034.
  • Kumar V, Surve A, Kumawat D, Takkar B, Azad S, Chawla R, Shroff D, Arora A, Singh R, Venkatesh P, et al. Ultra-wide field retinal imaging: a wider clinical perspective. Indian J Ophthalmol. 2021;69(4):824–35. doi:10.4103/ijo.IJO_1403_20.
  • Kumar T, Sharma GS, Singh LR. Homocystinuria: therapeutic approach. Clin Chim Acta. 2016;458:55–62. doi:10.1016/j.cca.2016.04.002.
  • Al-Sadeq DW, Thanassoulas A, Islam Z, Kolatkar P, Al-Dewik N, Safieh-Garabedian B, Nasrallah GK, Nomikos M. Pyridoxine non-responsive p.R336C mutation alters the molecular properties of cystathionine beta-synthase leading to severe homocystinuria phenotype. Biochim Biophys Acta Gen Subj. 2022;1866(7):130148. doi:10.1016/j.bbagen.2022.130148.
  • Fredrick DR. Myopia. BMJ. 2002;324(7347):1195–9. doi:10.1136/bmj.324.7347.1195.
  • Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050–8. doi:10.1001/archopht.119.7.1050.
  • Toprak AB, Eser E, Guler C, Baser FE, Mayali H. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol. 2005;12(4):259–69. doi:10.1080/09286580590967763.
  • Mulvihill A, Yap S, O’Keefe M, Howard PM, Naughten ER. Ocular findings among patients with late-diagnosed or poorly controlled homocystinuria compared with a screened, well-controlled population. J Aapos. 2001;5(5):311–5. doi:10.1067/mpa.2001.118219.
  • Al-Dewik N, Ali A, Mahmoud Y, Shahbeck N, Ali R, Mahmoud L, Al‐Mureikhi M, Al‐Mesaifri F, Musa S, El‐Akouri K, et al. Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population. J Inherit Metab Dis. 2019;42(5):818–30. doi:10.1002/jimd.12099.
  • Gus PI, Donis KC, Marinho D, Martins TF, de Souza CFM, Carloto RB, et al. Ocular manifestations in classic homocystinuria. Ophthalmic Genet. 2021;42(1):71–4. doi:10.1080/13816810.2020.1821384.
  • Pawar S, Parkar A, Menon S, Desai N, Namrata D, Dole K. Assessment of quality of life of the patients with diabetic retinopathy using National Eye Institute Visual Functioning Questionnaire (VFQ-25). J Healthc Qual Res. 2021;36(4):225–30. doi:10.1016/j.jhqr.2021.02.004.
  • DeCarlo DK, Forte E, Gao L, McGwin G, Owsley C. Reliability and validity of the PedsQL 4.0 generic core scales in pediatric vision impairment. J AAPOS. 2020;24(2):94.1–.7. doi:10.1016/j.jaapos.2020.01.008.
  • Nilsson M, Kolagari HT, Epstein D, Samolov B, Olsson M, Naess K, Oscarson M, Teaer Fahnehjelm K. Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease. Ophthalmic Genet. 2022;1–9. doi:10.1080/13816810.2022.2132515.